Back to portoflio
Biotech

ARMR Sciences Inc.

Invest. stage
Series A
Invest. DATe
November 2024
Investor(s)
Gunal Construction
founder
Dr. Ofer Levy, Dr. David Dowling, JR Rahn, Collin Gage, Stacy McIntosh, Dr. Colin Haile
amazing founder

Pioneers of Life-Saving Innovation

At the helm of ARMR Sciences Inc’s groundbreaking advancements are its co-founders Ofer Levy, David Dowling, JR Rahn, Collin Gage, Stacy McIntosh, and Colin Haile. United by a shared mission to combat the opioid crisis, they are pioneering innovative solutions, including a revolutionary fentanyl vaccine, to address one of the most pressing public health challenges of our time.

With their combined expertise in medicine, biotechnology, and entrepreneurship, the ARMR Sciences Inc. team is transforming the landscape of addiction treatment. Their relentless pursuit of scientific breakthroughs and commitment to saving lives are setting new standards in medical innovation, inspiring a future where preventable overdoses become a thing of the past.

ARMR Sciences Inc.

Leading Innovation in Public Health

At MG Capital, we pride ourselves on partnering with companies that drive meaningful change, and ARMR Sciences Inc. exemplifies this commitment to excellence. As a pioneering force in biotechnology, ARMR Sciences Inc. is revolutionizing the fight against the opioid crisis, developing life-saving solutions like its groundbreaking fentanyl vaccine to combat overdose fatalities and protect communities worldwide.

our portfolio

Only bold companies

We identify, evaluate, and invest decisively in groundbreaking opportunities within AI, biotech, ecological transition, and alternative energy, driving innovation and creating lasting impact.

View portfolio